PB 35 of 2024
National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 3)
I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination:
Dated 27 March 2024
NIKOLAI TSYGANOV
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 3).
This instrument may also be cited as PB 35 of 2024.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 April 2024 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
- Schedule 1 – entry for Anastrozole
Omit
Anastrozole | Tablet 1 mg | Oral | Arimidex | 30 | 9.24 | 13.00 |
Insert
Anastrozole | Tablet 1 mg | Oral | Arimidex | 30 | 7.26 | 10.21 |
2. Schedule 1 – entry for Donepezil
Omit
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aricept | 28 | 7.44 | 15.20 |
| Tablet containing donepezil hydrochloride 10 mg | Oral | Aricept | 28 | 7.44 | 15.15 |
Insert
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aricept | 28 | 5.46 | 11.16 |
| Tablet containing donepezil hydrochloride 10 mg | Oral | Aricept | 28 | 5.46 | 11.12 |
3. Schedule 1 – entry for Duloxetine
Omit
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Cymbalta | 28 | 3.86 | 18.15 |
| Capsule 60 mg (as hydrochloride) | Oral | Cymbalta | 28 | 4:38 | 18.64 |
Insert
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Cymbalta | 28 | 3.86 | 18.15 |
| Capsule 60 mg (as hydrochloride) | Oral | Cymbalta | 28 | 4.00 | 17.02 |
4. Schedule 1 – entry for Fluconazole
Omit
Fluconazole | Capsule 50 mg | Oral | Diflucan | 28 | 7.95 | 12.43 |
| Capsule 100 mg | Oral | Diflucan | 28 | 15.47 | 20.79 |
| Capsule 200 mg | Oral | Diflucan | 28 | 30.14 | 39.07 |
Insert
Fluconazole | Capsule 50 mg | Oral | Diflucan | 28 | 5.93 | 9.27 |
| Capsule 100 mg | Oral | Diflucan | 28 | 11.53 | 15.49 |
| Capsule 200 mg | Oral | Diflucan | 28 | 22.47 | 29.13 |
5. Schedule 1 – Omit entry for Glatiramer
6. Schedule 1 – entry for Gliclazide
Omit
Gliclazide | Tablet 60 mg (modified release) | Oral | Diamicron 60mg MR | 60 | 4.48 | 11.64 |
Insert
Gliclazide | Tablet 60 mg (modified release) | Oral | Diamicron 60mg MR | 60 | 3.92 | 10.19 |
7. Schedule 1 – entry for Lamotrigine
Omit
Lamotrigine | Tablet 25 mg | Oral | Lamictal | 56 | 4.25 | 8.48 |
| Tablet 50 mg | Oral | Lamictal | 56 | 7.08 | 11.22 |
| Tablet 100 mg | Oral | Lamictal | 56 | 11.79 | 15.93 |
| Tablet 200 mg | Oral | Lamictal | 56 | 19.82 | 23.96 |
Insert
Lamotrigine | Tablet 25 mg | Oral | Lamictal | 56 | 4.00 | 7.98 |
| Tablet 50 mg | Oral | Lamictal | 56 | 5.48 | 8.68 |
| Tablet 100 mg | Oral | Lamictal | 56 | 9.13 | 12.34 |
| Tablet 200 mg | Oral | Lamictal | 56 | 15.35 | 18.56 |
8. Schedule 1 – entry for Letrozole
Omit
Letrozole | Tablet 2.5 mg | Oral | Femara 2.5 mg | 30 | 13.88 | 17.38 |
Insert
Letrozole | Tablet 2.5 mg | Oral | Femara 2.5 mg | 30 | 9.72 | 12.17 |
9. Schedule 1 – entry for Levonorgestrel with ethinylestradiol
Omit
Levonorgestrel with ethinylestradiol | Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets | Oral | Levlen ED | 4 | 4.75 | 9.37 |
Insert
Levonorgestrel with ethinylestradiol | Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets | Oral | Levlen ED | 4 | 4.00 | 7.89 |
10. Schedule 1 – entry for Metformin
Omit
Metformin | Tablet containing metformin hydrochloride 500 mg | Oral | Diabex | 100 | 3.00 | 8.09 |
| Tablet (extended release) containing metformin hydrochloride 500 mg | Oral | Diabex XR 500 | 120 | 4.01 | 8.99 |
| Tablet containing metformin hydrochloride 850 mg | Oral | Diabex 850 | 60 | 3.00 | 8.09 |
| Tablet containing metformin hydrochloride 1 g | Oral | Diabex 1000 | 90 | 4.36 | 9.32 |
| Tablet (extended release) containing metformin hydrochloride 1 g | Oral | Diabex XR 1000 | 60 | 4.01 | 8.99 |
Insert
Metformin | Tablet containing metformin hydrochloride 500 mg | Oral | Diabex | 100 | 3.00 | 8.09 |
| Tablet (extended release) containing metformin hydrochloride 500 mg | Oral | Diabex XR 500 | 120 | 4.00 | 8.97 |
| Tablet containing metformin hydrochloride 850 mg | Oral | Diabex 850 | 60 | 3.00 | 8.09 |
| Tablet containing metformin hydrochloride 1 g | Oral | Diabex 1000 | 90 | 4.00 | 8.55 |
| Tablet (extended release) containing metformin hydrochloride 1 g | Oral | Diabex XR 1000 | 60 | 4.00 | 8.97 |
11. Schedule 1 – after entry for Methylphenidate
Insert
Methylprednisolone | Cream containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan | 1 | 4.95 | 8.61 |
| Fatty ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan (Fatty) | 1 | 4.95 | 8.61 |
| Ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan | 1 | 4.95 | 8.61 |
12. Schedule 1 – entry for Methylprednisolone
Omit
Methylprednisolone | Injection containing methylprednisolone acetate 40 mg in 1 mL | Injection | Depo‑Medrol | 5 | 10.58 | 13.01 |
13. Schedule 1 – entry for Moclobemide
Omit
Moclobemide | Tablet 150 mg | Oral | Aurorix | 60 | 7.79 | 10.19 |
| Tablet 300 mg | Oral | Aurorix 300 mg | 60 | 13.00 | 15.40 |
Insert
Moclobemide | Tablet 150 mg | Oral | Aurorix | 60 | 6.14 | 8.03 |
| Tablet 300 mg | Oral | Aurorix 300 mg | 60 | 10.24 | 12.13 |
14. Schedule 1 – entry for Modafinil
Omit
Modafinil | Tablet 100 mg | Oral | Modavigil | 60 | 72.13 | 78.33 |
Insert
Modafinil | Tablet 100 mg | Oral | Modavigil | 60 | 55.60 | 60.38 |
15. Schedule 1 – entry for Olmesartan
Omit
Olmesartan | Tablet containing olmesartan medoxomil 20 mg | Oral | Olmetec | 30 | 3.83 | 7.09 |
| Tablet containing olmesartan medoxomil 40 mg | Oral | Olmetec | 30 | 6.95 | 9.74 |
Insert
Olmesartan | Tablet containing olmesartan medoxomil 20 mg | Oral | Olmetec | 30 | 3.83 | 7.09 |
| Tablet containing olmesartan medoxomil 40 mg | Oral | Olmetec | 30 | 5.67 | 7.95 |
16. Schedule 1 – entry for Olmesartan with amlodipine
Omit
Olmesartan with amlodipine | Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) | Oral | Sevikar 40/5 | 30 | 5.96 | 8.35 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) | Oral | Sevikar 40/10 | 30 | 6.39 | 8.78 |
Insert
Olmesartan with amlodipine | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) | Oral | Sevikar 20/5 | 30 | 3.62 | 6.41 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) | Oral | Sevikar 40/5 | 30 | 5.96 | 8.75 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) | Oral | Sevikar 40/10 | 30 | 6.39 | 9.18 |
17. Schedule 1 – entry for Olmesartan with hydrochlorothiazide
Omit
Olmesartan with hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg | Oral | Olmetec Plus | 30 | 4.00 | 5.29 |
| Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg | Oral | Olmetec Plus | 30 | 7.11 | 11.02 |
| Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg | Oral | Olmetec Plus | 30 | 8.04 | 10.78 |
Insert
Olmesartan with hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg | Oral | Olmetec Plus | 30 | 4.00 | 6.79 |
| Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg | Oral | Olmetec Plus | 30 | 5.49 | 8.51 |
| Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg | Oral | Olmetec Plus | 30 | 6.20 | 8.31 |
18. Schedule 1 – entry for Tamoxifen
Omit
Tamoxifen | Tablet 20 mg (as citrate) | Oral | Nolvadex‑D | 30 | 6.27 | 9.50 |
Insert
Tamoxifen | Tablet 20 mg (as citrate) | Oral | Nolvadex‑D | 30 | 4.97 | 7.53 |
19. Schedule 1 – entry for Valproic Acid
Omit
Valproic Acid | Tablet (enteric coated) containing sodium valproate 200 mg | Oral | Epilim EC | 100 | 4.63 | 5.42 |
| Tablet (enteric coated) containing sodium valproate 500 mg | Oral | Epilim EC | 100 | 9.17 | 9.96 |
Insert
Valproic Acid | Tablet (enteric coated) containing sodium valproate 200 mg | Oral | Epilim EC | 100 | 4.00 | 4.68 |
| Tablet (enteric coated) containing sodium valproate 500 mg | Oral | Epilim EC | 100 | 7.47 | 8.11 |